IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 112 filers reported holding IRADIMED CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $908,520 | -54.2% | 20,476 | -50.7% | 0.18% | -52.4% |
| Q2 2023 | $1,984,456 | -41.9% | 41,568 | -45.4% | 0.37% | -42.1% |
| Q1 2022 | $3,416,000 | +60.1% | 76,179 | +64.9% | 0.64% | +81.7% |
| Q4 2021 | $2,134,000 | +33.6% | 46,186 | -2.9% | 0.35% | +29.6% |
| Q3 2021 | $1,597,000 | +134.2% | 47,547 | +96.0% | 0.27% | +61.7% |
| Q1 2019 | $682,000 | -60.1% | 24,263 | -65.3% | 0.17% | -64.0% |
| Q4 2018 | $1,709,000 | -24.8% | 69,850 | +14.1% | 0.46% | +37.3% |
| Q3 2018 | $2,274,000 | +198.0% | 61,207 | +66.4% | 0.34% | +181.7% |
| Q2 2018 | $763,000 | +83.9% | 36,774 | +25.0% | 0.12% | +73.9% |
| Q1 2018 | $415,000 | -9.2% | 29,426 | -2.4% | 0.07% | -15.9% |
| Q4 2017 | $457,000 | -79.3% | 30,141 | -61.8% | 0.08% | -71.6% |
| Q4 2015 | $2,213,000 | +15.5% | 78,945 | +0.4% | 0.29% | -4.6% |
| Q3 2015 | $1,916,000 | +5.4% | 78,634 | +0.7% | 0.30% | +42.3% |
| Q2 2015 | $1,818,000 | – | 78,105 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Ten Capital Management LLC | 715,877 | $32,100,000 | 4.18% |
| Soleus Capital Management, L.P. | 430,051 | $19,283,000 | 2.49% |
| RESOURCE CONSULTING GROUP INC | 128,000 | $5,740,000 | 1.99% |
| RK Capital | 213,200 | $9,560,000 | 1.88% |
| Capital Impact Advisors, LLC | 22,797 | $1,022,000 | 0.74% |
| G2 Investment Partners Management LLC | 61,326 | $2,750,000 | 0.65% |
| EAM Investors, LLC | 76,179 | $3,416,000 | 0.64% |
| Ranger Investment Management | 193,306 | $8,668,000 | 0.55% |
| EAM Global Investors LLC | 42,885 | $1,923,000 | 0.36% |
| Hillsdale Investment Management Inc. | 121,500 | $5,448,000 | 0.35% |